Concepedia

Author

Matthias Büchler

Centre Hospitalier Universitaire de Tours

Also Known As

Buchler Matthias, Buchler, Matthias, Büchler Matthias, Emmanuel Morelon, MATTHIAS BUCHLER, Matthias Buchler, Matthias Büchler

82

Publications

2.2K

Citations

25

H-Index

42

Concepts

All Affiliations

Centre Hospitalier Universitaire de ToursUniversité de ToursInsermHôpital BretonneauCentre National de la Recherche Scientifique
MB

About

Matthias Büchler is an author at Centre Hospitalier Universitaire de Tours specializing in medicine, kidney transplant, and nephrology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

540

2

Public Health

1

1

97

3

Biostatistics

1

1

34

4

Cell Biology

1

1

12

5

Cellular Therapies

1

1

27

Matthias Büchler

×

41

Publications

2K

Citations

24

H-Index

YearCitations

Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy

Yvon Lebranchu, Frank Bridoux, Matthias Büchler,

American Journal of Transplantation

2002

254

Early Low‐Grade Proteinuria: Causes, Short‐Term Evolution and Long‐Term Consequences in Renal Transplantation

Jean‐Michel Halimi, I. Laouad, Matthias Büchler,

American Journal of Transplantation

2005

142

Efficacy and tolerability of rituximab with or without PEGylated interferon alfa‐2b plus ribavirin in severe hepatitis C virus–related vasculitis: A long‐term followup study of thirty‐two patients

Benjamin Terrier, David Saadoun, D. Sène,

Arthritis & Rheumatism

2009

110

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

Olivier Thaunat, Camille Legeai, Dany Anglicheau,

Kidney International

2020

97

Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study

Hélio Tedesco‐Silva, Julio Pascual, Ondřej Viklický,

Transplantation

2019

93

Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies

Denis Glotz, Graeme R. Russ, Lionel Rostaing,

American Journal of Transplantation

2019

89

Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.

Mathilde de Menthon, Pascal Cohen, Christian Pagnoux,

PubMed

2011

78

Respective Predictive Role of Urinary Albumin Excretion and Nonalbumin Proteinuria on Graft Loss and Death in Renal Transplant Recipients

Jean‐Michel Halimi, Matthias Büchler, Azmi Al-Najjar,

American Journal of Transplantation

2007

77

Induction therapy by anti‐thymocyte globulin (rabbit) in renal transplantation: a 1‐yr follow‐up of safety and efficacy

Matthias Büchler, Bruno Hurault de Ligny, Corinne Madec,

Clinical Transplantation

2003

76

Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy

Chantal Le Guellec, Matthias Büchler, Bruno Giraudeau,

European Journal of Clinical Pharmacology

2001

75

Page 1